Analyzing the Impact of the Now iKnow Health Care Price Transparency Tool

NCT ID: NCT02053844

Last Updated: 2016-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

81000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to assess the impact of a web-based health care cost and quality tool that is being implemented by a health plan for its members. The study will focus on members working for medium to large employers that have more than 90% of employees enrolled in deductible and tiered network health plans. The study will use an interrupted time series (ITS) design that includes random allocation of half of these employers to a study arm that will receive enhanced promotion of the tool and a $500 lottery incentive for its use in order to increase take-up. With these two study groups (a "high-dose" group receiving enhanced promotion and a lottery, and a "low-dose" group receiving routine promotion of the tool), the study will be able to evaluate whether access to a price transparency tool leads to reduced costs and more value-driven member behavior, and whether extra promotion increases take-up.

Members in the high-dose group who use the tool will be eligible to enter a monthly lottery to win a $500 prize during the 12-month intervention period. In addition to the lottery, employers in the high-dose group will receive additional promotional strategies such as a mailing and messages through the plan's member web portal to promote the tool and the lottery, and e-mails and flyers for employers to promote the tool and lottery to employees.

The aims of this project are to: 1) examine take-up of the tool and factors that predict take-up; and 2) to examine the impact of the tool on total and out-of-pocket health care costs and utilization

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

no Specific Condition Targeted Use of a Price Transparency Tool

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lottery and enhanced promotion of tool

tool users in the intervention arm will be eligible to enter a monthly lottery to win one of two monthly drawings of a $500 gift card, and will receive enhanced promotion of the tool (mailed promotion, promotional message on the member web portal, and promotion through employers to employees)

Group Type EXPERIMENTAL

lottery for tool users to win a $500 prize

Intervention Type OTHER

Intervention group is eligible to enter a monthly lottery to win a $500 gift card if they use the tool each month.

enhanced promotion of the tool to employers and members

Intervention Type OTHER

Intervention group also receives extra promotion of the tool through mailings, employer outreach, and automated phone calls

usual promotion of the tool

Routine promotion of the tool through newsletter and on health plan web site

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lottery for tool users to win a $500 prize

Intervention group is eligible to enter a monthly lottery to win a $500 gift card if they use the tool each month.

Intervention Type OTHER

enhanced promotion of the tool to employers and members

Intervention group also receives extra promotion of the tool through mailings, employer outreach, and automated phone calls

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Health plan members from employers with at least 40 subscribers, of which at least 90% are currently in deductible plans or tiered network plans, and of which at least 80% were in deductible or tiered network plans in the prior year

Exclusion Criteria

Members in non-group accounts and members in Medicare plans; members in states outside Massachusetts, New Hampshire, or Maine
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

National Bureau of Economic Research, Inc.

OTHER

Sponsor Role collaborator

Harvard Pilgrim Health Care

OTHER

Sponsor Role collaborator

Massachusetts Institute of Technology

OTHER

Sponsor Role collaborator

Alison Galbraith

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alison Galbraith

Assistant Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alison Galbraith, MD, MPH

Role: STUDY_DIRECTOR

Harvard Pilgrim Health Care Institute and Harvard Medical Schooll

Jonathan Gruber, PhD

Role: PRINCIPAL_INVESTIGATOR

Massachusetts Institute of Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Harvard Pilgrim Health Care

Wellesley, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5P01AG005842-27

Identifier Type: NIH

Identifier Source: secondary_id

View Link

5P30AG012810-20

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.